paper-with-me

Papers

InteractionNet: Modeling and Explaining of Noncovalent Protein-Ligand Interactions with Noncovalent Graph Neural Network and Layer-Wise Relevance Propagation

2020-05-12 · Hyeoncheol Cho, Eok Kyun Lee, Insung S. Choi

Expanding the scope of graph-based, deep-learning models to noncovalent protein-ligand interactions has earned increasing attention in structure-based drug design. Modeling the protein-ligand interactions with graph neural networks (GNNs) has experienced difficulties in the conversion of protein-ligand complex structures into the graph representation and left questions regarding whether the trained models properly learn the appropriate noncovalent interactions. Here, we proposed a GNN architecture, denoted as InteractionNet, which learns two separated molecular graphs, being covalent and noncovalent, through distinct convolution layers. We also analyzed the InteractionNet model with an explainability technique, i.e., layer-wise relevance propagation, for examination of the chemical relevance of the model's predictions. Separation of the covalent and noncovalent convolutional steps made it possible to evaluate the contribution of each step independently and analyze the graph-building strategy for noncovalent interactions. We applied InteractionNet to the prediction of protein-ligand binding affinity and showed that our model successfully predicted the noncovalent interactions in both performance and relevance in chemical interpretation.

📄 PDF Abstract BibTeX arXiv:2005.13438

Code (0)

등록된 구현이 없습니다.

Tasks

Drug DesignGraph Neural Network

Methods 이 논문이 사용한 방법론

Convolution A convolution is a type of matrix operation, consisting of a kernel, a small matrix of weights, that slides over input data performing element-wise multiplication with the…

Similar Papers 제목 키워드 기반

FlexSBDD: Structure-Based Drug Design with Flexible Protein Modeling

2024-09-29 · Zaixi Zhang, Mengdi Wang, Qi Liu

Structure-based drug design (SBDD), which aims to generate 3D ligand molecules binding to target proteins, is a fundamental task in drug discovery. Existing SBDD methods typically treat protein as rigid and neglect prote…

Data AugmentationDrug DesignDrug Discovery

DiffBindFR: An SE(3) Equivariant Network for Flexible Protein-Ligand Docking

2023-11-26 · Jintao Zhu, Zhonghui Gu, Jianfeng Pei, Luhua Lai

Molecular docking, a key technique in structure-based drug design, plays pivotal roles in protein-ligand interaction modeling, hit identification and optimization, in which accurate prediction of protein-ligand binding m…

Drug DesignMolecular DockingPose Prediction

DeepPCM: Predicting Protein-Ligand Binding using Unsupervised Learned Representations

2019-09-25 · Paul Kim, Robin Winter, Djork-Arné Clevert

In-silico protein-ligand binding prediction is an ongoing area of research in computational chemistry and machine learning based drug discovery, as an accurate predictive model could greatly reduce the time and resources…

Computational chemistryDrug DiscoveryRepresentation Learning

FlexVDW: A machine learning approach to account for protein flexibility in ligand docking

2023-03-20 · Patricia Suriana, Joseph M. Paggi, Ron O. Dror

Most widely used ligand docking methods assume a rigid protein structure. This leads to problems when the structure of the target protein deforms upon ligand binding. In particular, the ligand's true binding pose is ofte…

Pose Prediction

Predicting Protein-Ligand Binding Affinity via Joint Global-Local Interaction Modeling

2022-09-18 · Yang Zhang, Gengmo Zhou, Zhewei Wei, Hongteng Xu

The prediction of protein-ligand binding affinity is of great significance for discovering lead compounds in drug research. Facing this challenging task, most existing prediction methods rely on the topological and/or sp…

Prediction